Catalysis Capital is a London-based life sciences specialist advisory boutique with early-stage venture investment activity in the United States. Its core sector focus spans life sciences, biotechnology, pharmaceuticals and medical devices, with an observed Series A investment signal in applied AI, education and future-of-work software.